Mirae Asset Global ETFs Holdings’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$354K Sell
17,656
-4,073
-19% -$81.7K ﹤0.01% 1989
2025
Q1
$428K Buy
21,729
+1,693
+8% +$33.3K ﹤0.01% 1954
2024
Q4
$451K Buy
20,036
+718
+4% +$16.2K ﹤0.01% 1975
2024
Q3
$493K Buy
19,318
+7,929
+70% +$203K ﹤0.01% 1919
2024
Q2
$266K Buy
+11,389
New +$266K ﹤0.01% 2121